Skip to main content
. 2009 Feb 2;53(4):1468–1475. doi: 10.1128/AAC.00339-08

TABLE 3.

Population PK parameter estimates for HCQ after administration of a single oral dose of HCQ sulfate (400 mg) in the PK studies (studies Ia, Ib, and II)a

Parameter ka (h−1) ALAG (h) IIV of ALAG Vc (liters) IIV of Vc Vp (liters) IIV of Vp Q (liters/h) CL/F (liters/h) IIV of CL/F ɛ1 (proportional) ɛ2 (additive)
Estimated value 1.15 0.389 0.0359 437 0.232 1,390 0.715 45.1 10.9 0.161 0.27b 2.77b
% RSE 15.7 8.8 61.1 17.8 57.8 17.8 22.3 16.6 21.5 41 7.3 37.5
95% CI 0.80-1.50 0.32-0.46 −0.09 284-589 −0.53 905-1,875 0.40-1.03 30.4-59.8 6.3-15.5 0.03-0.29 0.49-0.57 0.84-4.81
Bootstrap estimate 1.09 0.39 0.15 443 0.47 1,484 0.57 47.1 11.1 0.3 0.27 2.16
Bootstrap 95% CI 0.61-1.53 0.32-0.49 0.00-0.35 230-615 0.12-0.76 919-2,141 0.44-0.71 30.6-61.3 7.9-14.6 0.19-0.37 0.23-0.29 1.43-3.63
a

Abbreviations: RSE, relative standard error (standard error divided by the parameter estimate); CI, confidence interval; IIV, interindividual variability; ka, absorption rate constant; ALAG, absorption lag time; Vc, central volume of distribution; Vp, peripheral volume of distribution; Q, intercompartmental clearance.

b

The values represent standard deviations.